Company: EPR-PE
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001045450-25-000135
Chunk: 93

Company: EPR PROPERTIES
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 2
Chunk 93
---
,371 7,091 Impairment charges (4)— — — — 11,812 (11,812)Depreciation and amortization 42,409 42,795 (386)125,578 124,738 840 Gain (loss) on sale of real estate and early ground lease termination (5)8,073 (3,419)11,492 34,236 15,989 18,247 Costs associated with loan refinancing or payoff— 337 (337)— 337 (337)Interest expense, net 33,238 32,867 371 99,505 97,338 2,167 Equity in (income) loss from joint ventures (6)(2,934)851 (3,785)1,394 5,384 (3,990)Impairment charges on joint ventures (7)— 12,130 (12,130)— 12,130 (12,130)Income tax expense (benefit)725 (124)849 1,542 780 762 Preferred dividend requirements6,032 6,032 — 18,104 18,104 — 

(1) The decrease in other expense for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024 related primarily to a decrease in operating expense from three operating theatre properties that were sold during the nine months ended September 30, 2025.

(2) The increase in general and administrative expense for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024 related primarily to an increase in payroll and benefit costs, including annual incentive and share-based compensation. 

(3) The change in provision (benefit) for credit losses, net for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024 was due to credit loss expense of $6.2 million recognized to fully reserve one mortgage note receivable and changes in our estimated current expected credit losses mostly due to macro-economic conditions.

33

(4) Impairment charges recognized during the nine months ended September 30, 2024 related to one theatre property. No impairment charges were recognized during the three and nine months ended September 30